Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial (SMMT:NASDAQ)
6+ min ago (17+ words) Ivonescimab beat Keytruda in a China Phase 3 NSCLC trial, cutting death risk 27% and extending survival....
Salivary Nitrite Shifts Reveal Tumor-Specific Cancer Patterns, Suggests Systematic Review
2+ hour, 44+ min ago (183+ words) A recent systematic review published in the Indian Journal of Otolaryngology and Head & Neck Surgery in September 2026 reveals that salivary nitrite concentrations display striking, tumor-specific shifts in cancer patients. While nitrite levels surge in oral squamous cell carcinoma, they decline…...
Myeloma Paper of the Day, September 13th, Suggested by Robert Orlowski - OncoDaily
1+ hour, 2+ min ago (253+ words) Myeloma Paper of the Day, September 13th, Suggested by Robert Orlowski / Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer,, Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer, Christoph Schaefers, Darin Carabenciov, Erin Wiedmeier-Nutor, Joselle Cook,…...
Julie McCrossin: The Future of Proton Therapy in Australia - OncoDaily
1+ hour, 13+ min ago (135+ words) “Proton Therapy is in the news in Australia due to two unsuccessful attempts to introduce this form of radiotherapy into Australia. Here is the latest ABC News story on this issue referring to a series on ABC Radio National’s Background…...
Stephanie Haddad: Honored to Be Included in the Ethical Leadership Spotlight at Holy Cross - OncoDaily
35+ min ago (128+ words) Stephanie Haddad, Hematology/Oncology Fellow Physician and Wellness Chief Fellow at Mays Cancer Center at UT Health San Antonio, shared on X: “Honored to be included in the Ethical Leadership Spotlight at my alma mater, College of the Holy Cross! My…...
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
4+ hour, 36+ min ago (171+ words) Sep 13, 2026, 08:54 ET For decades, PCI has been used after initial therapy for SCLC because studies conducted before routine MRI demonstrated that it reduced brain metastases and improved overall survival. MAVERICK was designed to determine whether modern MRI surveillance could allow…...
SICK OF IT ALL's PETE KOLLER: LOU KOLLER 'Wanted Us To Keep The Band Going' After His Death
34+ min ago (432+ words) Guitarist Pete Koller of New York hardcore legends SICK OF IT ALL says that Lou Koller wanted the band to "keep going" after his death. The SICK OF IT ALL vocalist died in July after a long battle with an…...
Miguel Bronchud: A New Molecular Switch in Prostate Cancer Treatment Resistance
31+ min ago (480+ words) “Prostate cancers – ‘maybe lost in translation’? New hopes for more effective treatments ‘This is the first time anyone’s ever shown that the identity of the cell can be regulated by inhibiting translation’ said at the Fred Hutch Institute in Seattle…...
Jeremy Clarkson's decision to share prostate cancer diagnosis helped thousands
2+ hour, 30+ min ago (214+ words) Jeremy Clarkson's decision to make his prostate cancer diagnosis public has reportedly helped thousands. The former Top Gear presenter, who is now in remission, disclosed his illness in the recent series of Clarkson's Farm. This minimally invasive procedure uses high-frequency…...
September Stakeholder Webcast on ROBBIN Phase 3 and Neoadjuvant Immunotherapy - Agenus - OncoDaily
45+ min ago (100+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...